USX:MOLN - Molecular Partners AG

Molecular Partners AG ADR
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2013 Q4	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q2	2016 Q4	2017 Q2	2017 Q4	2018 Q2	2018 Q4	2019 Q2	2019 Q4	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1.22K% -	-741.13% -	-683.65% -	58.41% -	62.37% 6.8%	62.22% -0.2%	62.17% -0.1%	-252.43% -	-724.16% -	-685.53% -	-880.7% -	-870.22% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1.2K% -	-743.88% -	-679.73% -	59.39% -	61.97% 4.3%	61.38% -1.0%	61.52% 0.2%	-257.36% -	-713.57% -	-683.01% -	-868.26% -	-919.98% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.83M 615.1%	9.1M 56.0%	9.33M 2.5%	181.27M 1842.9%	189.83M 4.7%	188.64M -0.6%	189.56M 0.5%	19.83M -89.5%	8.49M -57.2%	8.7M 2.4%	7.04M -19.1%	6.73M -4.4%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	206.13M -	176.36M -14.4%	172.67M -2.1%	311.8M 80.6%	299.29M -4.0%	281.16M -6.1%	262.26M -6.7%	244.53M -6.8%	230.49M -5.7%	218.12M -5.4%	198.35M -9.1%	185.61M -6.4%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	72.05M -	51.94M -27.9%	65.38M 25.9%	47.34M -27.6%	33.42M -29.4%	29.73M -11.0%	27.09M -8.9%	22.37M -17.4%	24.52M 9.6%	21.91M -10.6%	21.92M 0.1%	17.06M -22.2%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	134.08M -	124.42M -7.2%	107.29M -13.8%	264.46M 146.5%	265.87M 0.5%	251.43M -5.4%	235.17M -6.5%	222.16M -5.5%	205.98M -7.3%	196.21M -4.7%	176.43M -10.1%	168.55M -4.5%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-53.38M -	-69.27M -	-90.95M -	102.48M -	112.57M 9.8%	113.5M 0.8%	118.57M 4.5%	-61.54M -	-62.24M -	-57.28M -	-59.01M -	-59.51M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	47.12M -64.8%	77.17M 63.8%	133.72M 73.3%	106.16M -20.6%	126.57M 19.2%	82.91M -34.5%	71.81M -13.4%	142.02M 97.8%	114.94M -19.1%	69.7M -39.4%	87.95M 26.2%	73.93M -15.9%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	127.12M 19.7%	82.02M -35.5%	71.81M -12.4%	143.19M 99.4%	113.71M -20.6%	67.88M -40.3%	87.95M 29.6%	74.49M -15.3%	66.79M -10.3%	72.33M 8.3%	67.31M -6.9%	72.13M 7.2%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-54.32M -	-70.51M -	-92.26M -	100.95M -	111.23M 10.2%	112.32M 1.0%	117.15M 4.3%	-62.74M -	-63.47M -	-58.41M -	-59.81M -	-60.29M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-71.29M -	-67.44M -	-63.78M -	105.88M -	118.39M 11.8%	117.37M -0.9%	117.85M 0.4%	-50.05M -	-61.52M -	-59.63M -	-61.98M -	-58.53M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-71.29M -	-67.44M -	-63.78M -	105.88M -	118.39M 11.8%	117.37M -0.9%	117.85M 0.4%	-50.05M -	-61.52M -	-59.63M -	-61.98M -	-58.53M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.36 -	-2.27 -	-2.06 -	3.13 -	3.55 13.4%	3.52 -0.8%	3.54 0.6%	-1.56 -	-1.9 -	-1.83 -	-1.89 -	-1.78 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-86.43% -	-54.2% -	-59.47% -	40.04% -	59.12% 47.7%	62.46% 5.6%	68.83% 10.2%	-20.57% -	-26.07% -	-26.64% -	-30.12% -	-29.96% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-51.07% -	-38.24% -	-35.42% -	33.96% -	46.77% 37.7%	51.31% 9.7%	54.19% 5.6%	-17.99% -	-23.22% -	-23.89% -	-26.91% -	-27.21% -